Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network
Open accessAbstract
Importance: Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years after initial diabetes diagnosis for youths with type 1 diabetes; the American Diabetes Association recommends screening of youths with type 2 diabetes at the time of initial diagnosis. To our knowledge, it is unknown to what extent youths with diabetes obtain eye examinations in accordance with these guidelines. Objective: To assess the rate of obtaining ophthalmic examinations and factors associated with receipt of eye examinations for youths with diabetes. Design, Setting, and Participants: This retrospective, longitudinal cohort study examined youths 21 years or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through December 31, 2014. Main Outcomes and Measures: Kaplan-Meier survival curves estimated the time from initial diabetes diagnosis to first eye examination by an ophthalmologist or optometrist. Multivariable Cox proportional hazards regression models identified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis. Results: Among 5453 youths with type 1 diabetes (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505 white [82.6%]) and 7233 youths with type 2 diabetes (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 5052 white [69.9%]), 64.9% of patients with type 1 diabetes and 42.2% of patients with type 2 diabetes had undergone an eye examination by 6 years after initial diabetes diagnosis. Black youths (1367 [10.8%] of the sample) had an 11% and Latino youths (1450 [11.4%] of the sample) had an 18% decreased hazard of undergoing an eye examination by 6 years compared with white youths (black youths: adjusted hazard ratio [HR], 0.89; 95% CI, 0.79-0.99; Latino youths: HR, 0.82; 95% CI, 0.73-0.92). As household net worth increased, youths were increasingly more likely to undergo an eye examination by 6 years after initial diabetes diagnosis (net worth of ≥$500 000 vs <$25 000: HR, 1.50; 95% CI, 1.34-1.68). Conclusions and Relevance: Despite possessing health insurance, many youths with diabetes are not receiving eye examinations by 6 years after initial diagnosis to monitor for DR. These data suggest that adherence to clinical practice guidelines is particularly challenging for racial minorities and youths from less affluent families.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only 35-72% of diabetic youth undergo recommended screening exams, with even higher care gap rates in minority and lower socioeconomic background youth.
“However, only 35-72% of diabetic youth undergo recommended screening exams, with even higher care gap rates in minority and lower socioeconomic background youth10,17.”
From Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial (2024) · cites this paper as [10]
The Discussion reports that 42.2% of youths with type 2 diabetes and 64.9% with type 1 diabetes received an eye examination within six years of diagnosis, and identifies lower examination rates among Black, Latino, and less affluent youths. It also cites rates of 35% and 70–72% from prior studies, but the 35% figure measures referrals rather than completed exams, while the 70–72% figure measures examinations around a transition in care rather than adherence to recommended screening. No page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Increasing Incidence of Type 1 Diabetes in Youth
Lipman, T. H., Levitt Katz, L. E., Ratcliffe, S. J., Murphy, K. M., Aguilar, A., Rezvani, I., Howe, C. J., Fadia, S., & Suarez, E. (2013) · Diabetes Care · doi:10.2337/dc12-0767 · Cited by 116 · see citing works
Adherence to Guidelines and its Effects on Hospitalizations with Complications of Type 2 Diabetes
Sloan, F. A., Bethel, M. A., Lee, P. P., Brown, D. S., & Feinglos, M. N. (2004) · The Review of Diabetic Studies · doi:10.1900/rds.2004.1.29 · Cited by 41 · see citing works
Flagged first, then by citations
Research works printed but not linked: 33
- [1]Green A Patterson CC EURODIAB TIGER Study Group Trends in the incidence of childhood-onset diabetes in Europe 1989–1998 Diabetologia 2001 44 3 suppl 3 B3 B8 11724413
- [2]Lin W-H Wang M-C Wang W-M Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study PLoS One 2014 9 1 e86172 24465941 PMC3899133
- [4]Dabelea D Mayer-Davis EJ Saydah S SEARCH for Diabetes in Youth Study Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009 JAMA 2014 311 17 1778 1786 24794371 PMC4368900
- [6]Pinhas-Hamiel O Zeitler P The global spread of type 2 diabetes mellitus in children and adolescents J Pediatr 2005 146 5 693 700 15870677
- [7]D’Adamo E Caprio S Type 2 diabetes in youth: epidemiology and pathophysiology Diabetes Care 2011 34 suppl 2 S161 S165 21525449 PMC3632155
- [8]Imperatore G Boyle JP Thompson TJ SEARCH for Diabetes in Youth Study Group Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth Diabetes Care 2012 35 12 2515 2520 23173134 PMC3507562
- [9]Broe R Early risk stratification in pediatric type 1 diabetes Acta Ophthalmol 2015 93 Thesis 1 1 1 19 25703648
- [10]Porta M Allione A Diabetic retinopathy and its relevance to paediatric age An update Pediatr Endocrinol Rev 2004 1 4 404 411 16437031
- [11]Thomas RL Dunstan FD Luzio SD Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service Br J Ophthalmol 2015 99 1 64 68 25091950
- [12]Lian JX Gangwani RA McGhee SM Chan CK Lam CL Wong DS Primary Health Care Group Systematic screening for diabetic retinopathy (DR) in Hong Kong: prevalence of DR and visual impairment among diabetic population Br J Ophthalmol 2016 100 2 151 155 26271268
- [13]Nathan DM Long-term complications of diabetes mellitus N Engl J Med 1993 328 23 1676 1685 8487827
- [16]Lueder GT Silverstein J American Academy of Pediatrics Section on Ophthalmology and Section on Endocrinology Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus Pediatrics 2005 116 1 270 273 15995070
- [17]American Diabetes Association Standards of medical care in diabetes–2010 Diabetes Care 2010 33 suppl 1 S11 S61 20042772 PMC2797382
- [19]Rosenberg JB Friedman IB Gurland JE Compliance with screening guidelines for diabetic retinopathy in a large academic children’s hospital in the Bronx J Diabetes Complications 2011 25 4 222 226 21177125
- [20]Valent D Pestak K Otis M Shubrook J Type 2 diabetes in the pediatric population: are we meeting ADA clinical guidelines in Ohio? Clin Pediatr (Phila) 2010 49 4 316 322 19745096
- [21]Schoenfeld ER Greene JM Wu SY Leske MC Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program Ophthalmology 2001 108 3 563 571 11237912
- [22]Dorsey RR Songer TJ Zgibor JC Orchard TJ Influences on screening for chronic diabetes complications in type 1 diabetes Dis Manag 2006 9 2 93 101 16620195
- [24]Schneider EW Mruthyunjaya P Talwar N Harris Nwanyanwu K Nan B Stein JD Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade Invest Ophthalmol Vis Sci 2014 55 1 542 549 24346174 PMC3907135
- [25]Wubben TJ Talwar N Blachley TS Rates of Vitrectomy among Enrollees in a United States Managed Care Network, 2001–2012 Ophthalmology 2016 123 3 590 598 26746595
- [26]Vanderbeek BL Zacks DN Talwar N Nan B Musch DC Stein JD Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network Am J Ophthalmol 2011 152 2 273 282.e3 21696700 PMC3143259
- [27]Vanderloo SE Johnson JA Reimer K Validation of classification algorithms for childhood diabetes identified from administrative data Pediatr Diabetes 2012 13 3 229 234 21771232
- [28]Brown M Kuhlman D Larson L Does availability of expanded point-of-care services improve outcomes for rural diabetic patients? Prim Care Diabetes 2013 7 2 129 134 23523626
- [30]Nakhla M Daneman D To T Paradis G Guttmann A Transition to adult care for youths with diabetes mellitus: findings from a Universal Health Care System Pediatrics 2009 124 6 e1134 e1141 19933731
- [31]Puent BD Nichols KK Patients’ perspectives on noncompliance with diabetic retinopathy standard of care guidelines Optometry 2004 75 11 709 716 15597813
- [32]Hartnett ME Key IJ Loyacano NM Horswell RL Desalvo KB Perceived barriers to diabetic eye care: qualitative study of patients and physicians Arch Ophthalmol 2005 123 3 387 391 15767483
- [33]Muñoz B O’Leary M Fonseca-Becker F Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes Arch Ophthalmol 2008 126 7 968 974 18625945 PMC2522366
- [34]Delorme C Boisjoly HM Baillargeon L Turcotte P Bernard PM Screening for diabetic retinopathy: do family physicians know the Canadian guidelines? Can Fam Physician 1998 44 1473 1479 9678276 PMC2277533
- [35]Wiggins MN Landes RD Bhaleeya SD Uwaydat SH Primary care physicians’ knowledge of the ophthalmic effects of diabetes Can J Ophthalmol 2013 48 4 265 268 23931464 PMC3863606
- [36]Kirkman MS Williams SR Caffrey HH Marrero DG Impact of a program to improve adherence to diabetes guidelines by primary care physicians Diabetes Care 2002 25 11 1946 1951 12401737
- [37]Garg S Jani PD Kshirsagar AV King B Chaum E Telemedicine and retinal imaging for improving diabetic retinopathy evaluation Arch Intern Med 2012 172 21 1677 1678 23026969
- [38]Kolomeyer AM Nayak NV Simon MA Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitus J Pediatr Ophthalmol Strabismus 2014 51 5 299 306 25020279
- [39]Tapley JL McGwin G Jr Ashraf AP Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study Diabetol Metab Syndr 2015 7 56 26136849 PMC4487844
- [40]Patty L Wu C Torres M Azen S Varma R Los Angeles Latino Eye Study Group Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study Ophthalmology 2012 119 9 1725 1730 22537615 PMC3413787
Cited by
Sorted by citations
Wolf, R. M., Channa, R., Liu, T. Y. A., Zehra, A., Bromberger, L., Patel, D., Ananthakrishnan, A., Brown, E. A., Prichett, L., Lehmann, H. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44676-z · Cited by 116 · see citing works
Wolf, R. M., Channa, R., Abramoff, M. D., & Lehmann, H. P. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.3190 · Cited by 87 · see citing works
Liu, J., Gibson, E., Ramchal, S., Shankar, V., Piggott, K., Sychev, Y., Li, A. S., Rao, P. K., Margolis, T. P., Fondahn, E., et al. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2020.06.016 · Cited by 88 · see citing works
Wolf, R. M., Liu, T. Y. A., Thomas, C., Prichett, L., Zimmer-Galler, I., Smith, K., Abramoff, M. D., & Channa, R. (2021) · Diabetes Care · doi:10.2337/dc20-1671 · Cited by 62 · see citing works
Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths
Thomas, C. G., Channa, R., Prichett, L., Liu, T. Y. A., Abramoff, M. D., & Wolf, R. M. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2021.1551 · Cited by 46 · see citing works
Wolf, R. M., Channa, R., Lehmann, H. P., Abramoff, M. D., & Liu, T. Y. A. (2024) · Clinical Diabetes · doi:10.2337/cd23-0019 · Cited by 12 · see citing works
- Authors
- Wang, S. Y., Andrews, C. A., Gardner, T. W., Wood, M., Singer, K., & Stein, J. D.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Stein, Joshua D.
- ORCID
- Venue
- JAMA Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-05-01
- Volume
- 135
- Issue
- 5
- Pages
- 432
- ISSN
- 2168-6165 (ISSN-L)
- PMC
- PMC5567866
- OpenAlex
- W2604037227
- Cited by
- 56
- References
- 2
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 11 · 2019: 4 · 2018: 6 · 2017: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- JAMA Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp3dk094292-01)
- National Eye Institute (R01EY026641, R01EY020582)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK101755, DP3-DK-094292, P30DK092926, P30DK020572)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Epidemiology › Ophthalmology and Visual Impairment Studies
- Keywords
- diabetic retinopathy screening, youth with diabetes, type 1 diabetes, type 2 diabetes, managed care, health care utilization, racial and ethnic disparities, blindness prevention, newly diagnosed diabetes, household net income, insurance status, geographic access to care
- MeSH terms
- Adolescent, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Humans, Male, Managed Care Programs, Patient Compliance, Retrospective Studies, United States, Vision Screening, Incidence, Guideline Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review